Bank of Nova Scotia Has $1.95 Million Stock Holdings in The Cooper Companies, Inc. $COO

Bank of Nova Scotia decreased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 88.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 27,302 shares of the medical device company’s stock after selling 203,805 shares during the quarter. Bank of Nova Scotia’s holdings in Cooper Companies were worth $1,952,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in COO. Heartland Advisors Inc. bought a new position in shares of Cooper Companies in the 4th quarter valued at $15,348,000. Wealth Enhancement Advisory Services LLC grew its position in Cooper Companies by 212.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 31,455 shares of the medical device company’s stock worth $2,652,000 after acquiring an additional 21,383 shares during the last quarter. Assetmark Inc. increased its holdings in Cooper Companies by 21.0% in the 4th quarter. Assetmark Inc. now owns 184,410 shares of the medical device company’s stock worth $15,114,000 after purchasing an additional 31,980 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Cooper Companies by 6.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company’s stock worth $34,224,000 after purchasing an additional 23,896 shares in the last quarter. Finally, Capital International Inc. CA raised its position in Cooper Companies by 22.9% in the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock valued at $9,688,000 after purchasing an additional 22,054 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on COO shares. Wells Fargo & Company reissued a “sell” rating and set a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. BNP Paribas Exane cut their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Finally, Mizuho set a $85.00 target price on shares of Cooper Companies and gave the stock an “outperform” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and a consensus target price of $81.36.

Cooper Companies Trading Up 1.4%

NASDAQ COO opened at $73.06 on Thursday. The business’s 50-day moving average price is $67.97 and its two-hundred day moving average price is $71.87. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The firm has a market capitalization of $14.25 billion, a PE ratio of 61.92, a price-to-earnings-growth ratio of 1.88 and a beta of 0.84. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.